IFI-M · HPB Tri-Axis Balanced Series

Specimen SS-F-M3-00205 // MULTI-AXIS · IFI-M

HPB Tri-Axis Balanced Series I-NP

Capsicum chinense

Habanero

Tier IHPB Tri-Axis Balanced Series

Target Trait

1×

fold-change

Heat+Sharp+Bitter-Attenuation balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-00205

Genomic Edits

5

GC Content

48.5%

Construct Length

3,732 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPV1 + TRPA1 + TAS2R38 (suppression)

IFI Score

100

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HPB pathway operation
  • Cross-pathway regulatory circuit for balanced HPB triple-axis expression

Key Interventions

Triple-axis receptor co-activation: TRPV1, TRPA1, and TAS2R38 (suppression) pathways simultaneously engineeredBalanced tri-axis expression strategy (HPB) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I HPB triple-axis construct for advanced multi-modal sensory architecture combining heat, sharp, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$549 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?